Further studies on the mechanism for the antithrombotic effects of naroparcil, an orally active thiozyloside compound.

Masson, P; Theveniaux, J; Coup, D; Grégoire, T; Vaillot, M; Dupouy, D; Sié, P; Boneu, B; Millet, J

Masson, P; Theveniaux, J; Coup, D; Grégoire, T; Vaillot, M; Dupouy, D; Sié, P; Boneu, B; Millet, J.

Affiliation

Masson P; Laboratoires Fournier, Research Center, Thrombosis Group, Daix, France. p.masson@fournier.fr

Thromb Haemost ; 81(6): 945-50, 1999 Jun.

Article in En | MEDLINE | ID: mdl-10404773

Subject(s)

Antithrombins/administration & dosage; Blood Coagulation/drug effects; Heparin Cofactor II/metabolism; Thioglycosides/administration & dosage; Venous Thrombosis/drug therapy; Administration, Oral; Animals; Drug Interactions; Heparin Cofactor II/administration & dosage; Male; Rabbits; Rats; Thioglycosides/blood; Venous Thrombosis/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thioglycosides / Blood Coagulation / Heparin Cofactor II / Antithrombins / Venous Thrombosis Type of study: Prognostic_studies / Qualitative_research Limits: Animals Language: En Journal: Thromb Haemost Year: 1999 Document type: Article Affiliation country: France Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links